FFA
HAE icon

Farther Finance Advisors’s Haemonetics HAE Stock Holding History

Farther Finance Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$99.6K Buy
946
+339
+56% +$31.5K ﹤0.01% 2861
2026
Q2 		$45.5K Sell
607
-25
-4% -$1.61K ﹤0.01% 3310
2026
Q1 		$35.5K Sell
632
-155
-20% -$10.1K ﹤0.01% 3234
2025
Q4 		$63.1K Buy
787
+677
+615% +$45.5K ﹤0.01% 2660
2025
Q3 		$5.36K Hold
110
– – ﹤0.01% 3730
2025
Q2 		$8.21K Buy
110
+43
+64% +$2.85K ﹤0.01% 3174
2025
Q1 		$4.22K Buy
67
+31
+86% +$2.11K ﹤0.01% 3134
2024
Q4 		$2.81K Hold
36
– – ﹤0.01% 2879
2024
Q3 		$2.89K Buy
36
+1
+3% +$81 ﹤0.01% 2859
2024
Q2 		$2.9K Hold
35
– – ﹤0.01% 2638
2024
Q1 		$2.97K Sell
35
-5
-13% -$392 ﹤0.01% 2323
2023
Q4 		$3.42K Buy
40
+28
+233% +$2.42K ﹤0.01% 2167
2023
Q3 		$1.07K Buy
+12
New +$1.07K ﹤0.01% 2064

Other funds holding HAE

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's HAE Position: Q3 2026 in Review

Farther Finance Advisors increased its Haemonetics (HAE) stake by 56% in Q3 2026, buying an estimated $31.5K and bringing the position to 946 shares worth $99.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2861.

Farther Finance Advisors first reported a position in HAE in Q3 2023 and has held it in 13 quarters since. 7 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Farther Finance Advisors held 946 shares of Haemonetics worth $99.6K as of Q3 2026.
  • Farther Finance Advisors bought 339 Haemonetics shares in Q3 2026, an estimated $31.5K.
  • Haemonetics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2861 holding.
  • Farther Finance Advisors first reported a position in Haemonetics in Q3 2023 and has held it in 13 quarters since.
  • 7 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.